WTAP and hepatocellular carcinoma: These results demonstrate that hepatic deletion of Wtap promotes HCC progression through activating GRB2–ERK1/2-mediated signaling pathway depending on the downregulation of proteasome-related genes especially Psmb4 and Psmb6.